The regulation of CXCL12 expression by promoter hypermethylation is common in colon carcinoma [7] and breast cancer, suggesting that tumour cells that silence CXCL12 are at a selective advantage for metastasis [6,27]. Here, CXCL12 is linked to breast carcinoma.